Press release
Natural Killer (NK) Cells Therapy Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments by DelveInsight
Natural Killer (NK) Cells Therapy Pipeline
Natural Killer Cells Therapy Overview
Natural killer cells, also known as NK cells are a type of lymphocytes and are key components of the innate immune system. They are highly specific predators that play a major role in the host rejection of both tumors and viral infected cells. NK cells have cytotoxic small granules, which contain special proteins such as perfins and proteases, which are known as granzymes in their cytoplasm. Perforins form pores in the cell membrane of the target cell through which the granzymes and associated molecules induce apoptosis.
"Natural Killer Cells Therapy Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Natural Killer Cells Therapy Market.
The Natural Killer Cells Therapy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Natural Killer Cells Therapy Pipeline Report: https://www.delveinsight.com/report-store/natural-killer-nk-cell-lymphoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Natural Killer Cells Therapy treatment therapies with a considerable amount of success over the years. Natural Killer Cells Therapy Key players such as - ONK Therapeutics, Navrogen, Chimeric Therapeutics, Catamaran Bio, fate Therapeutics, Gamida-Cell, Artiva Biotherapeutics, Dragonfly therapeutics, Affimed, XNK Therapeutics, Glycostem, CELLID, SMT bio Co., Ltd., Innate Pharma, and others, are developing therapies for the Natural Killer Cells Therapy treatment
• Natural Killer Cells Therapy Emerging therapies such as - ONKT102, NAV-001, CHM 0201, CAT-179, FT516, GDA-201, AB 101, DF1001, AFM13, Evencaleucel, GTA002, BVAC-C, SMT-NK, Monalizumab, and others are expected to have a significant impact on the Natural Killer Cells Therapy market in the coming years.
• In June 2022, SMT bio Co., Ltd. Initiated a randomized, placebo-controlled, open-label,phase IIb clinical trial to evaluate the antitumor activity of combination therapy of SMT-NK and pembrolizumab vs. pembrolizumab monotherapy in patients with advanced Biliary Tract Cancer.
• In September 2021, Nektar Therapeutics announced it has entered into a new oncology clinical collaboration with MerckKGaA, Darmstadt, Germany and Pfizer Inc. to evaluate the maintenance regimen of NKTR-255, Nektar's interleukin-15 (IL15) receptor agonist, in combination with a velumab, a PD-L1 inhibitor, in patients with locally advanced or metastatic urothelial carcinoma (UC) in the Phase II JAVELIN Bladder Medley study.
Natural Killer Cells Therapy Pipeline Therapeutics Assessment
• Natural Killer Cells Therapy Assessment by Product Type
• Natural Killer Cells Therapy By Stage and Product Type
• Natural Killer Cells Therapy Assessment by Route of Administration
• Natural Killer Cells Therapy By Stage and Route of Administration
• Natural Killer Cells Therapy Assessment by Molecule Type
• Natural Killer Cells Therapy by Stage and Molecule Type
DelveInsight's Natural Killer Cells Therapy Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Emerging Natural Killer Cells Therapy Drugs Under Different Phases of Clinical Development Include:
• ONKT102: ONK Therapeutics
• NAV-001: Navrogen
• CHM 0201: Chimeric Therapeutics
• CAT-179: Catamaran Bio
• FT516: fate Therapeutics
• GDA-201: Gamida-Cell
• AB 101: Artiva Biotherapeutics
• DF1001: Dragonfly therapeutics
• AFM13: Affimed
• Evencaleucel: XNK Therapeutics
• GTA002: Glycostem
• BVAC-C: CELLID
• SMT-NK: SMT bio Co., Ltd.
• Monalizumab: Innate Pharma
Natural Killer Cells Therapy Pipeline Analysis:
The Natural Killer Cells Therapy pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the Natural Killer Cells Therapy treatment with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Natural Killer Cells Therapy Treatment.
• Natural Killer Cells Therapy key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Natural Killer Cells Therapy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Natural Killer Cells Therapy market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Natural Killer Cells Therapy product details are provided in the report. Download the Natural Killer Cells Therapy pipeline report to learn more about the emerging Natural Killer Cells Therapy therapies at:
https://www.delveinsight.com/sample-request/natural-killer-nk-cell-lymphoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Natural Killer Cells Therapy Pipeline Market Drivers
• Increasing interest towards NK Cell Therapies among biotech and pharma companies • Increase in collaborations and acquisitions between companies
• Increase in clinical and pre-clinical research with positive results
Natural Killer Cells Therapy Pipeline Market Barriers
• Cumbersome preparation method of CAR NK cells
• Autologous NK cells cannot serve as an effective treatment modality for solid tumors
Get a Free Sample PDF Report to know more about Natural Killer Cells Therapy Pipeline Assessment- https://www.delveinsight.com/sample-request/natural-killer-nk-cell-lymphoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of Natural Killer Cells Therapy Pipeline Drug Insight
• Coverage: Global
• Key Natural Killer Cells Therapy Companies: ONK Therapeutics, Navrogen, Chimeric Therapeutics, Catamaran Bio, fate Therapeutics, Gamida-Cell, Artiva Biotherapeutics, Dragonfly therapeutics, Affimed, XNK Therapeutics, Glycostem, CELLID, SMT bio Co., Ltd., Innate Pharma, and others
• Key Natural Killer Cells Therapy Therapies: ONKT102, NAV-001, CHM 0201, CAT-179, FT516, GDA-201, AB 101, DF1001, AFM13, Evencaleucel, GTA002, BVAC-C, SMT-NK, Monalizumab, and others
• Natural Killer Cells Therapy Therapeutic Assessment: Natural Killer Cells Therapy current marketed and Natural Killer Cells Therapy emerging therapies
• Natural Killer Cells Therapy Market Dynamics: Natural Killer Cells Therapy market drivers and Natural Killer Cells Therapy market barriers
Request for Sample PDF Report for Natural Killer Cells Therapy Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/natural-killer-nk-cell-lymphoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Natural Killer Cells Therapy Report Introduction
2 Natural Killer Cells Therapy Executive Summary
3 Natural Killer Cells Therapy Overview
4 Natural Killer Cells Therapy- Analytical Perspective In-depth Commercial Assessment
5 Natural Killer Cells Therapy Pipeline Therapeutics
6 Natural Killer Cells Therapy Late Stage Products (Phase II/III)
7 Natural Killer Cells Therapy Mid Stage Products (Phase II)
8 Natural Killer Cells Therapy Early Stage Products (Phase I)
9 Natural Killer Cells Therapy Preclinical Stage Products
10 Natural Killer Cells Therapy Therapeutics Assessment
11 Natural Killer Cells Therapy Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Natural Killer Cells Therapy Key Companies
14 Natural Killer Cells Therapy Key Products
15 Natural Killer Cells Therapy Unmet Needs
16 Natural Killer Cells Therapy Market Drivers and Barriers
17 Natural Killer Cells Therapy Future Perspectives and Conclusion
18 Natural Killer Cells Therapy Analyst Views
19 Appendix
20 About DelveInsight
Download Sample PDF Report to know more about Natural Killer Cells Therapy drugs and therapies- https://www.delveinsight.com/sample-request/natural-killer-nk-cell-lymphoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Natural Killer (NK) Cells Therapy Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments by DelveInsight here
News-ID: 2852701 • Views: …
More Releases from DelveInsight Business Research
Spasticity Clinical Pipeline 2025: A Comprehensive Review of 12+ Emerging Therap …
According to DelveInsight's latest analysis, the global Spasticity pipeline features more than 10 active pharmaceutical companies that are advancing over 12 investigational therapies. The report offers a detailed evaluation of clinical trials, mechanisms of action, therapeutic approaches, routes of administration, and major developmental activities shaping the Spasticity treatment landscape.
DelveInsight's report, "Spasticity Pipeline Insight, 2025," delivers an extensive overview of the current clinical development environment and the future outlook for the…
Real-World Evidence Solution Market is set to grow at a 8.07% CAGR, reaching USD …
According to DelveInsight, the real-world evidence (RWE) solutions market is expanding rapidly, primarily due to the increasing global burden of chronic diseases and the growing need to improve healthcare outcomes. In addition, advancements in big data analytics, artificial intelligence, and machine learning are enhancing the ability to efficiently process and interpret large-scale real-world datasets. The rising adoption of RWE solutions by pharmaceutical and biotechnology companies - to support drug development,…
Spinal Implants Market is set to grow at a 5.50% CAGR, reaching USD 21.9 billion …
According to DelveInsight's assessment, the rising burden of spinal disorders particularly within the growing elderly population - continues to significantly increase the demand for surgical correction procedures. Alongside this, the surge in sports-related injuries and trauma cases is accelerating the need for advanced implantable spinal solutions. There is also a notable shift toward non-fusion and motion-preserving devices that support spinal flexibility and enhance patient outcomes, especially for younger and more…
Vascular Stents Market is set to grow at a 6.65% CAGR, reaching USD 18.28 billio …
According to DelveInsight's assessment, the rising global burden of cancer is significantly increasing the demand for advanced treatment approaches such as tumor ablation. Minimally invasive ablation techniques are gaining strong traction due to their advantages, including faster recovery times, lower complication risks, and reduced costs compared with traditional surgical procedures. At the same time, continuous improvements in ablation technologies - particularly in radiofrequency, microwave, and cryoablation systems - have enhanced…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
